Clinical Trials Directory

Trials / Completed

CompletedNCT02404623

The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity

The Effect of Vitamin D Administration to Premature Infants on Vitamin D Status and Respiratory Morbidity During the First Year of Life

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
50 (actual)
Sponsor
Soroka University Medical Center · Academic / Other
Sex
All
Age
33 Weeks – 37 Weeks
Healthy volunteers
Accepted

Summary

This trial objective is to assess whether doubling the daily intake of vitamin D improves serum vitamin D levels and serves as primary prevention of respiratory infections and asthma in premature infants. This is a prospective randomized (1:1) double-blinded trial. The study population will be randomized into two groups (1:1): * Intervention Group - 800 IU of Vitamin D once daily * Control Group - 400 IU of Vitamin D once daily Patients will be followed up for one year after randomization for serum Vitamin D levels and respiratory morbidity.

Detailed description

The rational of this trial is that a daily supplementation of a double dose of Vitamin D (800 IU instead of 400 IU) to late premature infants during the first year of life will result in elevated Vitamin D serum levels and in an improvement in respiratory morbidity. This randomized trial of vitamin D supplementation is planned to determine the optimal dose of daily vitamin D supplementation required to achieve sufficient vitamin D levels in preterm infants and to assess whether doubling the daily intake of vitamin D may serve as primary prevention of respiratory infections and asthma in premature infants.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTVitamin Dalso known as Cholecalciferol, is one of the two most important compounds within the group of Vitamin D. It can be ingested from the diet and from supplements. In this study it is pharmacologically acquired and referred to as Vitamin D

Timeline

Start date
2015-04-01
Primary completion
2018-02-12
Completion
2018-02-12
First posted
2015-03-31
Last updated
2018-02-14

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT02404623. Inclusion in this directory is not an endorsement.